Adial Pharmaceuticals Inc (ADIL) Annual Balance Sheets

Annual · GAAP · USD millions
Access ADIL quarterly Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Adial Pharmaceuticals Inc adapts its asset base and funding mix.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent5.88
Cash & Short-term Investments5.00
Inventories0.00
Discontinued Operations0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.30
Total Current Assets6.18
Equipment/Property/Plant Net0.00
Goodwill net0.00
Intangible Assets0.00
Long-term investments0.49
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.49
Operating Lease Right Of Use Asset-
Acquired Inprocess Research And Development-
Total Assets6.67
Liabilities
Accounts Payable, Current AC0.66
Accrued Liabilities, Current AC0.74
Other Liabilities, Current0.00
Discontinued Operation, Liabilities0.00
Total Current Liabilities1.40
Long-term debt0.00
Capital Lease Obligations, Noncurrent LO0.00
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent0.00
Accounts Payable Related Party Currrent-
Total Liabilities1.40
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock95.25
Retained Earnings / Accumulated Deficit-89.97
Other Equity0.00
Common Stockholder's Equity5.28
Total Stockholder's Equity5.28
Liabilities & Stockholder's Equity6.67
4 historic quarters locked

Sign in to unlock the full Adial Pharmaceuticals Inc balance sheet history.

About Adial Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-024175

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.